First Trust Advisors LP Intra Cellular Therapies, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

A detailed history of First Trust Advisors LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 680,251 shares of ITCI stock, worth $56.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
680,251
Previous 583,592 16.56%
Holding current value
$56.1 Million
Previous $40 Million 24.44%
% of portfolio
0.05%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$67.99 - $80.84 $6.57 Million - $7.81 Million
96,659 Added 16.56%
680,251 $49.7 Million
Q2 2024

Aug 13, 2024
SELL
$64.76 - $79.84 $6.93 Million - $8.55 Million
-107,045 Reduced 15.5%
583,592 $40 Million
Q1 2024

May 13, 2024
BUY
$64.37 - $75.65 $43.8 Million - $51.4 Million
679,811 Added 6279.43%
690,637 $47.8 Million
Q4 2023

Feb 13, 2024
SELL
$46.37 - $73.65 $2.4 Million - $3.81 Million
-51,742 Reduced 82.7%
10,826 $775,000
Q3 2023

Nov 13, 2023
BUY
$52.09 - $64.1 $2.12 Million - $2.61 Million
40,649 Added 185.45%
62,568 $3.26 Million
Q2 2023

Aug 14, 2023
SELL
$54.67 - $66.44 $1.56 Million - $1.9 Million
-28,576 Reduced 56.59%
21,919 $1.39 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $832,068 - $1.08 Million
18,997 Added 60.31%
50,495 $2.73 Million
Q4 2022

Feb 09, 2023
SELL
$44.07 - $54.45 $2.86 Million - $3.54 Million
-64,957 Reduced 67.34%
31,498 $1.67 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $487,932 - $685,505
-11,427 Reduced 10.59%
96,455 $4.49 Million
Q2 2022

Aug 12, 2022
BUY
$43.0 - $65.64 $441,739 - $674,319
10,273 Added 10.52%
107,882 $6.16 Million
Q1 2022

May 13, 2022
BUY
$38.74 - $62.09 $1.5 Million - $2.41 Million
38,786 Added 65.94%
97,609 $5.97 Million
Q4 2021

Feb 08, 2022
SELL
$35.2 - $53.42 $1.81 Million - $2.74 Million
-51,282 Reduced 46.58%
58,823 $3.08 Million
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $1.67 Million - $2.47 Million
58,102 Added 111.73%
110,105 $4.11 Million
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $1.52 Million - $2.31 Million
52,003 New
52,003 $2.12 Million
Q1 2019

May 09, 2019
SELL
$10.9 - $14.09 $262,548 - $339,385
-24,087 Closed
0 $0
Q4 2018

Feb 07, 2019
BUY
$10.36 - $20.96 $249,541 - $504,863
24,087 New
24,087 $274,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.79B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email